Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)

This study has been terminated.

(Main objective of study was met. Further recruitment was difficult.)

Sponsor:

Information provided by:

Vifor Inc.

ClinicalTrials.gov Identifier:

NCT00882414

First received: April 15, 2009

Last updated: April 7, 2010

Last verified: April 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2010
Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)